{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:33:57Z","timestamp":1773927237519,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202008320278"],"award-info":[{"award-number":["202008320278"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153135","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:58:33Z","timestamp":1765817913000},"page":"153135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["N\u03b5-(carboxymethyl)lysine-modified albumin exacerbates doxorubicin-induced NOX5-dependent oxidative stress in endothelial cells"],"prefix":"10.1016","volume":"796","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-8230","authenticated-orcid":false,"given":"Zhu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg.S.E.","family":"Waas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suat","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris J.T.H.","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans W.M.","family":"Niessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.J.","family":"Krijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.153135_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.bbrc.2025.153135_bib2","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2025.153135_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5603\/KP.2016.0156","article-title":"[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]","volume":"74","author":"Zamorano","year":"2016","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.bbrc.2025.153135_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.bbrc.2025.153135_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2025.153135_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","article-title":"Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications","volume":"38","author":"Soultati","year":"2012","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bbrc.2025.153135_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bcp.2018.02.018","article-title":"Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction","volume":"150","author":"Sonowal","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.153135_bib8","article-title":"Calcitriol Attenuates doxorubicin-induced Cardiac dysfunction and inhibits endothelial-to-mesenchymal transition in mice","volume":"8","author":"Tsai","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.153135_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pharep.2015.03.022","article-title":"Detrimental effects of chemotherapeutics and other drugs on the endothelium: a call for endothelial toxicity profiling","volume":"67","author":"Wojcik","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbrc.2025.153135_bib10","doi-asserted-by":"crossref","first-page":"47266","DOI":"10.1074\/jbc.M106829200","article-title":"Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium","volume":"276","author":"Kalivendi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.153135_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","article-title":"Increased accumulation of the glycoxidation product N (Epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging","volume":"99","author":"Schleicher","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.153135_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-017-0531-9","article-title":"Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells","volume":"16","author":"Ren","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2025.153135_bib13","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.153135_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/eci.12599","article-title":"Prevention of age-induced N(\u03b5)-(carboxymethyl)lysine accumulation in the microvasculature","volume":"46","author":"Fuijkschot","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2025.153135_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI119180","article-title":"Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging","volume":"99","author":"Schleicher","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.153135_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/db13-1864","article-title":"Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)","volume":"64","author":"Hanssen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2025.153135_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biof.1018","article-title":"An update on advanced glycation endproducts and atherosclerosis","volume":"38","author":"Del Turco","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.bbrc.2025.153135_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2012.01.019","article-title":"Advanced glycation end-product N\u03b5-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes","volume":"221","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2025.153135_bib19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.bjc.6603640","article-title":"Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice","volume":"96","author":"Bruynzeel","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.153135_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tox.2009.12.004","article-title":"Involvement of advanced glycation end-products, pentosidine and n(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats","volume":"268","author":"Moriyama","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2025.153135_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/antiox13010112","article-title":"Pyridoxamine limits cardiac dysfunction in a rat model of doxorubicin-induced cardiotoxicity","volume":"13","author":"Haesen","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.153135_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/HYPERTENSIONAHA.120.16759","article-title":"Tumor necrosis factor alpha-mediated inflammation and remodeling of the extracellular matrix underlies aortic stiffening induced by the common chemotherapeutic agent Doxorubicin","volume":"77","author":"Clayton","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2025.153135_bib23","article-title":"P131 low doses OF advanced glycation end\u2013products and FRUCTOSILATION products PROMOTES premature cell death of human cardiac cells exposed to doxorubicin via activation of NLRP3, MYD88 and P53 downregulation","volume":"24","author":"Quagliariello","year":"2022","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.bbrc.2025.153135_bib24","article-title":"The receptor for advanced glycation endproducts amplifies doxorubicin cardiotoxicity","volume":"83","author":"Ikeda","year":"2024","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"key":"10.1016\/j.bbrc.2025.153135_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","article-title":"Endothelial NADPH oxidases: which NOX to target in vascular disease?","volume":"25","author":"Drummond","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2025.153135_bib26","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2025.153135_bib27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2008.07.063","article-title":"Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease","volume":"52","author":"Guzik","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib28","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.ajpath.2012.02.018","article-title":"NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans","volume":"180","author":"Hahn","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2025.153135_bib29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijcard.2022.10.172","article-title":"NOX2 and NOX5 are increased in cardiac microvascular endothelium of deceased COVID-19 patients","volume":"370","author":"Jiang","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112147","article-title":"NADPH oxidase 5 (NOX5) overexpression promotes endothelial dysfunction via cell apoptosis, migration, and metabolic alterations in human brain microvascular endothelial cells (hCMEC\/D3)","volume":"11","author":"Marqu\u00e9s","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.153135_bib31","doi-asserted-by":"crossref","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","article-title":"N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression","volume":"274","author":"Kislinger","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.153135_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj20030763","article-title":"Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry","volume":"375","author":"Thornalley","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2025.153135_bib33","doi-asserted-by":"crossref","first-page":"C272","DOI":"10.1152\/ajpcell.00091.2011","article-title":"Serum starvation: caveat emptor","volume":"301","author":"Pirkmajer","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00125-004-1455-y","article-title":"Elevated serum levels of N\u03b5-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema","volume":"47","author":"Boehm","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2025.153135_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ajh.2008.320","article-title":"Serum carboxymethyl\u2013Lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults","volume":"22","author":"Semba","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2025.153135_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10616-010-9263-3","article-title":"Albumin and mammalian cell culture: implications for biotechnology applications","volume":"62","author":"Francis","year":"2010","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbrc.2025.153135_bib37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2019.12.038","article-title":"Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation","volume":"148","author":"Dao","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.153135_bib38","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1161\/01.ATV.0000245794.45804.ab","article-title":"N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction?","volume":"26","author":"Baidoshvili","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.153135_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2025.153135_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13104-015-1000-8","article-title":"Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays","volume":"8","author":"van Tonder","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.bbrc.2025.153135_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1988.6.3.517","article-title":"Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans","volume":"6","author":"Mross","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.153135_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2025.153135_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.31768\/2312-8852.2017.39(4):308-311","article-title":"L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia","volume":"39","author":"Skrypnyk","year":"2017","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbrc.2025.153135_bib44","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1523-1755.2000.00340.x","article-title":"Nitric oxide inhibits the formation of advanced glycation end products","volume":"58","author":"Asahi","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2025.153135_bib45","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/S0024-3205(01)01352-2","article-title":"Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study","volume":"69","author":"Murata","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2025.153135_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/aging.100876","article-title":"miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway","volume":"8","author":"Yin","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2025.153135_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0735-1097(24)02356-8","article-title":"The receptor for advanced glycation ENDPRODUCTS amplifies doxorubicin cardiotoxicity","volume":"83","author":"Ikeda","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib48","doi-asserted-by":"crossref","unstructured":"V. Quagliariello, M. Iovine, G. D'Aiuto, S. Buccolo, C. Maurea, A. Bonelli, A. Paccone, M.L. Canale, N. Maurea, Low doses of advanced glycation end-products and fructosilation products promotes premature cell death of human cardiac cells and increases drug resistance of human breast cancer cells exposed to doxorubicin through NLRP3 and MyD88 pathways, J. Clin. Oncol. 40 e24055\u2013e24055. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.e24055.","DOI":"10.1200\/JCO.2022.40.16_suppl.e24055"},{"key":"10.1016\/j.bbrc.2025.153135_bib49","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1053\/ajkd.2001.27414","article-title":"Advanced glycation end products and the progressive course of renal disease","volume":"38","author":"Heidland","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2025.153135_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11764-014-0408-9","article-title":"Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin","volume":"9","author":"Qin","year":"2015","journal-title":"J. Canc. Surviv."},{"key":"10.1016\/j.bbrc.2025.153135_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fphys.2016.00334","article-title":"S100A8 and S100A9 are associated with doxorubicin-induced cardiotoxicity in the heart of diabetic mice","volume":"7","author":"Pei","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28106","article-title":"Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation","volume":"67","author":"Felicetti","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2025.153135_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2021.11.036","article-title":"Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: a possible role in the onset of late complications","volume":"178","author":"Felicetti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.153135_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413402","article-title":"Subcellular localization guides eNOS function","volume":"25","author":"Villadangos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.153135_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000885","article-title":"NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype","volume":"18","author":"Elbatreek","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2025.153135_bib56","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.108.168278","article-title":"Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase","volume":"28","author":"Zhang","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2025.153135_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5820415","article-title":"Tetramethylpyrazine Attenuates the endotheliotoxicity and the mitochondrial dysfunction by Doxorubicin via 14-3-3gamma\/Bcl-2","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2025.153135_bib58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1006\/jmcc.2002.2110","article-title":"Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies","volume":"34","author":"Wu","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2025.153135_bib59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fnins.2015.00421","article-title":"The Golgi complex in stress and death","volume":"9","author":"Machamer","year":"2015","journal-title":"Front. Neurosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:12:52Z","timestamp":1773915172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25018510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"alternative-id":["S0006291X25018510"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153135","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u03b5-(carboxymethyl)lysine-modified albumin exacerbates doxorubicin-induced NOX5-dependent oxidative stress in endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153135"}}